Long-term	long-term	O	O	O	O
prognosis	prognosis	O	O	O	O
for	for	O	O	O	O
transplant-free	transplant-free	O	O	O	O
survivors	survivors	O	O	O	O
of	of	O	O	O	O
paracetamol-induced	paracetamol-induced	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
prognosis	prognosis	O	O	O	O
for	for	O	O	O	O
transplant-free	transplant-free	O	O	O	O
survivors	survivors	O	O	O	O
of	of	O	O	O	O
paracetamol-induced	paracetamol-induced	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
remains	remains	O	O	O	O
unknown	unknown	O	O	O	O
.	.	O	O	O	O

AIM	aim	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
examine	examine	O	O	O	O
whether	whether	O	O	O	O
paracetamol-induced	paracetamol-induced	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
increases	increases	O	O	O	O
long-term	long-term	O	O	O	O
mortality	mortality	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
followed	followed	O	O	O	O
up	up	O	O	O	O
all	all	O	O	O	O
transplant-free	transplant-free	O	O	O	O
survivors	survivors	O	O	O	O
of	of	O	O	O	O
paracetamol-induced	paracetamol-induced	O	O	O	O
acute	acute	O	O	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
,	,	O	O	O	O
hospitalized	hospitalized	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
Danish	danish	O	O	O	O
national	national	O	O	O	O
referral	referral	O	O	O	O
centre	centre	O	O	O	O
during	during	O	O	O	O
1984	1984	O	O	O	O
-	-	O	O	O	O
2004	2004	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
compared	compared	O	O	O	O
age-specific	age-specific	O	O	O	O
mortality	mortality	O	O	O	O
rates	rates	O	O	O	O
from	from	O	O	O	O
1	1	O	O	O	O
year	year	O	O	O	O
post-discharge	post-discharge	O	O	O	O
through	through	O	O	O	O
2008	2008	O	O	O	O
between	between	O	O	O	O
those	those	O	O	O	O
in	in	O	O	O	O
whom	whom	O	O	O	O
the	the	O	O	O	O
liver	liver	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
led	led	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
and	and	O	O	O	O
those	those	O	O	O	O
in	in	O	O	O	O
whom	whom	O	O	O	O
it	it	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
included	included	O	O	O	O
641	641	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
average	average	O	O	O	O
,	,	O	O	O	O
age-specific	age-specific	O	O	O	O
mortality	mortality	O	O	O	O
rates	rates	O	O	O	O
were	were	O	O	O	O
slightly	slightly	O	O	O	O
higher	higher	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
101	101	O	O	O	O
patients	patients	O	O	O	O
whose	whose	O	O	O	O
paracetamol-induced	paracetamol-induced	O	O	O	O
liver	liver	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
had	had	O	O	O	O
caused	caused	O	O	O	O
an	an	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
(	(	O	O	O	O
adjusted	adjusted	O	O	O	O
mortality	mortality	O	O	O	O
rate	rate	O	O	O	O
ratio	ratio	O	O	O	O
=	=	O	O	O	O
1.70	1.70	O	O	O	O
,	,	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
CI	ci	O	O	O	O
1.02	1.02	O	O	O	O
-	-	O	O	O	O
2.85	2.85	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
the	the	O	O	O	O
association	association	O	O	O	O
was	was	O	O	O	O
age-dependent	age-dependent	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
no	no	O	O	O	O
survivors	survivors	O	O	O	O
of	of	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
died	died	O	O	O	O
of	of	O	O	O	O
liver	liver	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
,	,	O	O	O	O
whereas	whereas	O	O	O	O
suicides	suicides	O	O	O	O
were	were	O	O	O	O
frequent	frequent	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
observations	observations	O	O	O	O
speak	speak	O	O	O	O
against	against	O	O	O	O
long-term	long-term	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

More	more	O	O	O	O
likely	likely	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
elevated	elevated	O	O	O	O
mortality	mortality	O	O	O	O
rate	rate	O	O	O	O
ratio	ratio	O	O	O	O
resulted	resulted	O	O	O	O
from	from	O	O	O	O
incomplete	incomplete	O	O	O	O
adjustment	adjustment	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
greater	greater	O	O	O	O
prevalence	prevalence	O	O	O	O
of	of	O	O	O	O
substance	substance	O	O	OTHERS	I
abuse	abuse	O	O	OTHERS	I
among	among	O	O	O	O
survivors	survivors	O	O	O	O
of	of	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Paracetamol-induced	paracetamol-induced	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
affect	affect	O	O	O	O
long-term	long-term	O	O	O	O
mortality	mortality	O	O	O	O
.	.	O	O	O	O

Clinical	clinical	O	O	O	O
follow-up	follow-up	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
justified	justified	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
itself	itself	O	O	O	O
.	.	O	O	O	O

